RTE.ie·3 min read·medium
Weight loss drugs 'linked to hair loss' - study
R
RTÉ News
✦AI Summary
A new study involving 50,000 patients suggests that GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, are linked to a higher risk of hair loss. Researchers found that users of these weight loss and diabetes medications had a significantly higher incidence of alopecia compared to those on other treatments.
Weight loss and diabetes drugs like Mounjaro, Ozempic and Wegovy are linked to an increased risk of hair loss, according to researchers.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in